Cargando…
Research Needed to Support Clinical Use of Biomarkers as Prognostic Indicators for Patients with Heart Failure
Despite extensive research and numerous publications biomarkers have yet to fulfill their promise as prognostic indicators that can be widely used in the care of patients with heart failure. Specific clinical applications need to be identified for informative analyses of data that emphasize the most...
Autores principales: | Rector, Thomas S., Anand, Inder S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902010/ https://www.ncbi.nlm.nih.gov/pubmed/20631895 http://dx.doi.org/10.4061/2010/453851 |
Ejemplares similares
-
Stable but Progressive Nature of Heart Failure: Considerations for Primary Care Physicians
por: Anand, Inder
Publicado: (2018) -
Biomarkers in Heart Failure: From Research to Clinical Practice
por: Berezin, Alexander E., et al.
Publicado: (2023) -
Phenylacetylglutamine as a risk factor and prognostic indicator of heart failure
por: Zong, Xiao, et al.
Publicado: (2022) -
Serum Chemerin as a Novel Prognostic Indicator in Chronic Heart Failure
por: Zhou, Xiang, et al.
Publicado: (2019) -
Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers
por: Berezin, Alexander E.
Publicado: (2016)